Edge Therapeutics, Inc. 4
4 · Edge Therapeutics, Inc. · Filed Mar 15, 2017
Insider Transaction Report
Form 4
Faleck Herbert J
Chief Medical Officer
Transactions
- Award
Stock Option (right To Purchase)
2017-03-13$8.86/sh+110,000$974,600→ 110,000 totalExercise: $8.86Exp: 2027-03-13→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 110,000 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.